Skip to main content
Premium Trial:

Request an Annual Quote

Cellectis, Stemgent Partner on Genome Engineering, mRNA Reprogramming

NEW YORK (GenomeWeb News) – Cellectis bioresearch, a subsidiary of Cellectis group, today said that it has partnered with Stemgent to provide research services that combine mRNA reprogramming and genome engineering.

The firms said that the combination of their technologies would "pave the way for clinically-relevant applications in regenerative medicine." Terms of the alliance were not disclosed.

Cellectis' expertise is in gene editing and genome engineering. The firm's Talen-based genome-engineering technology enables direct introduction of disease-specific genetic mutations that mimic disease and reporter genes with fluorescent/luminescent tags to evaluate drug candidate efficacy, specificity, and toxicity.

Stemgent has developed an mRNA reprogramming technology to derive non-integrating, clinically-relevant induced pluripotent stem cells for use in regenerative medicine, drug discovery, and basic research.

"The challenge researchers face is that current models to test drugs are often inadequate," Ian Ratcliffe, president and CEO of Cambirdge, Mass.-based Stemgent, said in a statement. "With this partnership and the combined technologies, we can introduce mutations into reprogrammed cells and differentiate them into downstream lineages. Researchers can utilize these cells to test how mutations, known and unknown, alter the biology of the cells upon exposure to drugs."

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.